Pharmacologic Characterization of a Novel Non-Benzodiazepine Selective Anxiolytic, DN-2327.

The Japanese Journal of Pharmacology
doi 10.1254/jjp.49.337
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Pharmacological Society

Related search

Central Amygdala Circuit Dynamics Underlying the Benzodiazepine Anxiolytic Effect

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2018English

3. COPD: Non-Pharmacologic Treatment

Internal Medicine
Internal MedicineMedicine
2007English

Synthesis, Characterization and Biological Evaluation of Novel 1, 4-Benzodiazepine Derivatives as Potent Anti-Tubercular Agents

Journal of Young Pharmacists
ToxicologyPharmaceuticsPharmacology
2018English

The Synthesis and Evaluation of a Novel Inhibitor DN for Carbon Dioxide Corrosion

Open Journal of Composite Materials
2014English

682 Characterization of a Novel Selective Non-Steroidal Glucocorticoid Receptor Agonist With Low Systemic Exposure and Reduced Potential for Skin Atrophy

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

Antidepressant and Anxiolytic Effects of Selective 5-Ht6 Receptor Agonists in Rats

Psychopharmacology
Pharmacology
2010English

Anxiolytic and Antidepressant-Like Activities of the Novel and Potent Non-Imidazole Histamine H3 Receptor Antagonist ST-1283

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2014English

Development of a Class of Selective Cholecystokinin Type B Receptor Antagonists Having Potent Anxiolytic Activity.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1990English

Non-Pharmacologic Treatment of Migraine Using and Acupuncture: A Case Report

International Journal of Complementary & Alternative Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy